APA (7th ed.) Citation

Oyama, T., Nakai, S., Miyao, K., Imazeki, M., & Takeuchi, M. (2026). Necrotizing scleritis resistant to biologics successfully managed with the JAK inhibitor upadacitinib: A case report. Journal of Ophthalmic Inflammation & Infection, 16(1), 1. https://doi.org/10.1186/s12348-026-00580-3

Chicago Style (17th ed.) Citation

Oyama, Tomoyuki, Shunsaku Nakai, Kenji Miyao, Masaya Imazeki, and Masaru Takeuchi. "Necrotizing Scleritis Resistant to Biologics Successfully Managed with the JAK Inhibitor Upadacitinib: A Case Report." Journal of Ophthalmic Inflammation & Infection 16, no. 1 (2026): 1. https://doi.org/10.1186/s12348-026-00580-3.

MLA (9th ed.) Citation

Oyama, Tomoyuki, et al. "Necrotizing Scleritis Resistant to Biologics Successfully Managed with the JAK Inhibitor Upadacitinib: A Case Report." Journal of Ophthalmic Inflammation & Infection, vol. 16, no. 1, 2026, p. 1, https://doi.org/10.1186/s12348-026-00580-3.